期刊文献+

卡马西平对妊娠小鼠的致畸作用及叶酸的干预影响分析 被引量:2

原文传递
导出
摘要 目的:观察卡马西平对妊娠小鼠的不良作用,探讨叶酸对其不良效应的干预结果。方法:将100只雌性和50只雄性小鼠随机分为5组(雌雄比例2∶1),分别为:①空白对照组(灌胃蒸馏水,10 ml/kg);②卡马西平单次剂量组(100mg/kg);③卡马西平二次给药组(上、下午各为50 mg/kg);④卡马西平单次剂量与叶酸联合用药组(100 mg/kg+0.07 mg/kg);⑤卡马西平二次给药与叶酸联合用药组(上、下各为50 mg/kg+0.035 mg/kg)。观察小鼠是否受孕、流产、畸形、死胎、每窝仔鼠的数目及孕期增重情况等指标。结果:与其他各组相比,单剂量组小鼠的受孕率下降,孕鼠的流产率、死胎率和畸胎率均上升,孕期增重和每窝正常仔鼠数目减少(P<0.05)。与二次给药组和二次给药与叶酸组相比,单次剂量组和单次剂量与叶酸组小鼠的受孕率下降、死胎率上升(P<0.05);与单次剂量与叶酸组和二次给药与叶酸组相比,单次剂量组和二次给药组小鼠的受孕率下降、死胎率上升、孕期增重减少(P<0.05)。结论:卡马西平可导致妊娠小鼠妊娠意外的增多,小剂量多次给药以及补充叶酸可降低卡马西平的不良作用。
出处 《中国妇幼保健》 CAS 北大核心 2013年第8期1346-1348,共3页 Maternal and Child Health Care of China
  • 相关文献

参考文献9

  • 1Sweetman SC. Martindale [ M] . Thirty - third edition. Pharma- ceutical Press, 2002:337 - 371.
  • 2Miller PN, Partten MK, Beck F. Growth of 9.5 - dag rat em- bryos in folic - acid - deficient serum [ J]. Teratology, 1989, 39 (4) : 375.
  • 3潘映辐,陈葵,李秀华,孙迪.奥卡西平治疗癫癎的临床观察[J].临床神经病学杂志,2005,18(5):321-323. 被引量:34
  • 4常红升,朱明霞,廖琦,田卫卫,马银燕,毛新春.奥卡西平单药治疗和辅加治疗对国人癫疗效和副反应的对照研究[J].卒中与神经疾病,2008,15(4):230-233. 被引量:8
  • 5张碧藻.妊娠合并癫痫34例临床分析[J].大理学院学报(综合版),2009,8(10):69-71. 被引量:9
  • 6Holmes LB, Harvey EA, Coull BA et al. The teratogenicity of anticonvulsant drugs [J] . N Engl J Med, 2001, 344 (15) : 1132.
  • 7Wide K, Windbladh B, Kallen B. Major malformations in in- fants exposed to antiepileptic drugs in utero, with emphasis on carbamzepine and valproic acid: a nation -wide population - based register study [ J ] . Acta Paediatr, 2004, 93 ( 2 ) : 174.
  • 8Vajda FJE. Treatment options for pregnant women with epilepsy [ J] . Expert Opinion on Pharmacotherapy, 2008, 9 ( 11 ) : 1859.
  • 9Harden CL. Antiepileptic drug teratogenesis: what are the risks for congenital malformations and adverse cognitive outcomes?[J] . Int Rev Neurobiol, 2008, 83 : 205.

二级参考文献23

  • 1潘映辐,姬长莲,陈葵,周立春.拉莫三嗪对难治性癫痫的临床观察[J].临床神经病学杂志,1996,9(2):94-97. 被引量:11
  • 2Pennell PB, Newport DJ, Stowe ZN, et al. The impact of pregnancy and chilidbirth on the metabolism of lamotrigine [J].Neurology, 2004,62: 292-295.
  • 3Holmes LB, Harvey EA, Coull BA, et al. The teratogenicity of anticonvulsant drugs [J]. N Engl J med,2001,344: 1132-1138.
  • 4Wide K, Windbladh B, Kallen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamzepine and valproic acid: a nation-wide population-based register study[J]. Acta Paediatr, 2004, 93 : 174-176.
  • 5Neural Tube DesectS ACOD Bulletin. Clinical management guidelines for obstetrician- gynecologists [J]. Obstet Gynecol, 2002,102: 203-21.
  • 6Bill PA, Vigonius U, Pohlmann H, et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy [ J ]. Epilepsy Res, 1997,27:195.
  • 7Christe W, Kramer G, Vigonius U,et al. A double-blind controlled clinical trial of oxcarbazepine, versus sodium valproate in adults with nearly diagnosed epilepsy [ J ]. Epilepsy Res, 1997,26:451.
  • 8Dam M, Ekberg R, Loyning Y, et al. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy [ J ]. Epilepsy Res, 1989,3:70.
  • 9Guerreiro MM,Vigonius U, Pohlmann,et al. A double-blind controlled clinied trial, of oxcarbazepinc versus phenytoin in children and adolescents with epilepsy[ J]. Epilepsy Res, 1997,27:205.
  • 10Bares G, Walker EG, Elger CE, et al. Oxcarbazepine placebo-controlled dose-ranging trial in refracstory partial epilepsy [ J ]. Epilepsia,2000,12:1597.

共引文献47

同被引文献30

  • 1Tomson T,Battino D,Bonizzoni E,et al.Dose-dependent risk of malformations with antiepileptic drugs:an analysis of from the EURAP epilepsy and pregnancy registry[J].Lancet Neurol,2011,10(7):609-617.
  • 2Jentink J,Loane MA,Dolk H,et al.Valproic acid monotherapy in pregnancy and major congenital malformations[J].N Engl J Med,2010,362(23):2185-2193.
  • 3Jentink J,Dolk H,Loane MA,et al.Intrauterine exposure to carbamazepine and specific congenital malformations:systematic review and case-control[J].BMJ,2010,341:c6581.
  • 4Fisher RS,Acevedo C,Arzimanoglou A,et al.ILAE official report:a practical clinical definition of epilepsy[J].Epilepsia,2014,55(4):475-482.
  • 5Morrow J,Russell A,Guthrie E,et al.Malformation risks of antiepileptic dugs in pregnancy:a prospective study from the UK Epilepsy and Pregnancy Register[J].J Neurol Neurosurg Psychiatry,2006,77(2):193-198.
  • 6Yerby M,Koepsell T,Daling J.Pregnancy complication and outcome in a cohort of women with epilepsy[J].Epilepsia,1985,26(6):631-635.
  • 7Pennell PB,Newport DJ,Stowe ZN,et al.The impact of pregnancy and childbirth on the metabolism of lamotrigine[J].Neurology,2014,62(2):292-295.
  • 8Kalviainen R,Tomson T.Optimizing treatment of epilepsy during pregnancy[J].Neurology,2006,67(12 suppl 4):559-563.
  • 9杨宁,黎冰梅,刘晓蓉,邓宇虹,于美娟,廖卫平.抗癫痫药物及其他危险因素对妊娠癫痫妇女及胎儿的影响[J].国际医药卫生导报,2010,16(4):385-388. 被引量:3
  • 10阚淑娟,杨建春,李云霞.苯妥英钠对妊娠小鼠的致畸作用及叶酸的干预影响分析[J].中国妇幼保健,2011,26(27):4251-4253. 被引量:2

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部